Ryuji Sakata
Research Subjects
Ryuji Sakata has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Miho Ogawa
Department of Bacteriology, BML Inc., Kawagoe 350-1101, Japan
4 shared publications - Hajime Kanamori
Department of Infectious Diseases and Laboratory Medicine, Kanazawa University
2 shared publications - Kentarou Takei
Department of Infectious Diseases, Internal Medicine, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan
2 shared publications - Akiyo Nakano
Department of Microbiology and Infectious Diseases, Nara Medical University
1 shared publication - Hisakazu Yano
Department of Microbiology and Infectious Diseases, Nara Medical University, Kashihara, Nara, Japan
1 shared publication - Hisakazu Yano
Department of Microbiology and Infectious Diseases, Nara Medical University, 840 Shijo-cho, Kashihara-shi 6348521, Nara, Japan
1 shared publication
Latest Publications
- 27 October 2026
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
Antimicrobial Resistance and Molecular Epidemiology of Haemophilus influenzae Causing Pediatric Acute Otitis Media in Japan
Background: Antimicrobial-resistant strains of Haemophilus influenzae are associated with treatment failure and recurrence in acute otitis media (AOM). We aimed to characterize the current antimicrobial susceptibility of H. influenzae isolates from children with AOM, elucidate β-lactam and quinolone resistance mechanisms, and determine the molecular epidemiology of resistant strains. Methods: We analyzed 182 H. influenzae isolates from the middle ear fluid of children aged ≤3 years with AOM from multiple regions in Japan (February 2022–May 2023). Antimicrobial susceptibility was tested, and β-lactamase genes ( bla TEM-1 and bla ROB-1 ) were detected. Sequence analyses of ftsI, encoding PBP3 and quinolone resistance–determining regions were performed to elucidate the resistance mechanisms. Multilocus sequence typing (MLST) was conducted for the ampicillin- and quinolone–low-susceptible strains. Results: Of 182 isolates, 14 (7.7%), 10 (5.5%), 36 (19.8%) and 122 (67.0%) were β-lactamase–producing, β-lactamase–nonproducing ampicillin-resistant (BLNAR), low-BLNAR and β-lactamase–nonproducing ampicillin-susceptible strains, respectively. All 10 BLNAR and 4 β-lactamase–producing isolates exhibited group III PBP3 amino acid substitutions associated with high-level resistance. MLST revealed genetic diversity among BLNAR isolates, whereas 7 (50.0%) β-lactamase–producing isolates belonged to ST103, indicating clonal dissemination. Amino acid substitutions in the quinolone resistance–determining region were detected in six quinolone–low-susceptible strains; these isolates exhibited diverse STs. Conclusions: The β-lactam susceptibility of H. influenzae isolates causing pediatric AOM exhibited an overall improvement. However, an increasing trend in quinolone–low-susceptible strains was observed. Specific clones represented by ST103 were detected among some of the β-lactamase–producing strains, warranting careful monitoring.
- 27 October 2026
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
Antimicrobial Resistance and Molecular Epidemiology of Haemophilus influenzae Causing Pediatric Acute Otitis Media in Japan
Background: Antimicrobial-resistant strains of Haemophilus influenzae are associated with treatment failure and recurrence in acute otitis media (AOM). We aimed to characterize the current antimicrobial susceptibility of H. influenzae isolates from children with AOM, elucidate β-lactam and quinolone resistance mechanisms, and determine the molecular epidemiology of resistant strains. Methods: We analyzed 182 H. influenzae isolates from the middle ear fluid of children aged ≤3 years with AOM from multiple regions in Japan (February 2022–May 2023). Antimicrobial susceptibility was tested, and β-lactamase genes ( bla TEM-1 and bla ROB-1 ) were detected. Sequence analyses of ftsI, encoding PBP3 and quinolone resistance–determining regions were performed to elucidate the resistance mechanisms. Multilocus sequence typing (MLST) was conducted for the ampicillin- and quinolone–low-susceptible strains. Results: Of 182 isolates, 14 (7.7%), 10 (5.5%), 36 (19.8%) and 122 (67.0%) were β-lactamase–producing, β-lactamase–nonproducing ampicillin-resistant (BLNAR), low-BLNAR and β-lactamase–nonproducing ampicillin-susceptible strains, respectively. All 10 BLNAR and 4 β-lactamase–producing isolates exhibited group III PBP3 amino acid substitutions associated with high-level resistance. MLST revealed genetic diversity among BLNAR isolates, whereas 7 (50.0%) β-lactamase–producing isolates belonged to ST103, indicating clonal dissemination. Amino acid substitutions in the quinolone resistance–determining region were detected in six quinolone–low-susceptible strains; these isolates exhibited diverse STs. Conclusions: The β-lactam susceptibility of H. influenzae isolates causing pediatric AOM exhibited an overall improvement. However, an increasing trend in quinolone–low-susceptible strains was observed. Specific clones represented by ST103 were detected among some of the β-lactamase–producing strains, warranting careful monitoring.
- Open Access
- 11 May 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (10) , 4269
Phenotypic and Genetic Characteristics of blaIMP-6-Harboring Enterobacterales Isolates Lacking blaCTX-M-2 in Japan
Carbapenemase-producing Enterobacterales (CPE) is a global threat. IMP-6, a prevalent carbapenemase in western Japan, is mostly disseminated via CTX-M-2 extended-spectrum β-lactamase (ESBL) co-producing Enterobacterales. However, the existence and characteristics of Enterobacterales harboring blaIMP-6 without blaCTX-M-2 remain unclear. We analyzed the phenotypic and genetic characteristics of clinical blaIMP-6-harboring Enterobacterales isolates, focusing on those lacking blaCTX-M-2. Overall, 220 blaIMP-6-harboring isolates collected from 76 Japanese hospitals between 2014 and 2021 were characterized by antimicrobial susceptibility, presence of CTX-M-type ESBLs, plasmid incompatibility, plasmid transfer experiments, and genome sequencing and analysis. Among these, 203 co-harbored blaCTX-M-2 group, with 90% of them demonstrating high conjugation frequency and broad-spectrum resistance to β-lactams. Of the remaining 17 isolates, nine lacked blaCTX-M, while eight co-harbored blaCTX-M-1 group (n = 2) or blaCTX-M-9 group (n = 6). Eleven isolates carried nontransferable plasmids with genetic structures distinct from those of blaIMP-6 and blaCTX-M-2 co-encoding plasmids, including eight non-incompatibility N plasmids. Fifteen isolates carried only blaIMP-6-encoding plasmids; two carried plasmids with blaIMP-6 and blaCTX-M (blaCTX-M-27 or blaCTX-M-65). This novel study revealed that blaIMP-6 can exist without blaCTX-M-2 on diverse, often nontransferable plasmids, suggesting distinct, lower dissemination pathways compared to those of epidemic blaCTX-M-2 co-carrying plasmids and highlighting previously overlooked plasmids that necessitate close monitoring.
- 11 May 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (10) , 4269
Open AccessPhenotypic and Genetic Characteristics of blaIMP-6-Harboring Enterobacterales Isolates Lacking blaCTX-M-2 in Japan
Carbapenemase-producing Enterobacterales (CPE) is a global threat. IMP-6, a prevalent carbapenemase in western Japan, is mostly disseminated via CTX-M-2 extended-spectrum β-lactamase (ESBL) co-producing Enterobacterales. However, the existence and characteristics of Enterobacterales harboring blaIMP-6 without blaCTX-M-2 remain unclear. We analyzed the phenotypic and genetic characteristics of clinical blaIMP-6-harboring Enterobacterales isolates, focusing on those lacking blaCTX-M-2. Overall, 220 blaIMP-6-harboring isolates collected from 76 Japanese hospitals between 2014 and 2021 were characterized by antimicrobial susceptibility, presence of CTX-M-type ESBLs, plasmid incompatibility, plasmid transfer experiments, and genome sequencing and analysis. Among these, 203 co-harbored blaCTX-M-2 group, with 90% of them demonstrating high conjugation frequency and broad-spectrum resistance to β-lactams. Of the remaining 17 isolates, nine lacked blaCTX-M, while eight co-harbored blaCTX-M-1 group (n = 2) or blaCTX-M-9 group (n = 6). Eleven isolates carried nontransferable plasmids with genetic structures distinct from those of blaIMP-6 and blaCTX-M-2 co-encoding plasmids, including eight non-incompatibility N plasmids. Fifteen isolates carried only blaIMP-6-encoding plasmids; two carried plasmids with blaIMP-6 and blaCTX-M (blaCTX-M-27 or blaCTX-M-65). This novel study revealed that blaIMP-6 can exist without blaCTX-M-2 on diverse, often nontransferable plasmids, suggesting distinct, lower dissemination pathways compared to those of epidemic blaCTX-M-2 co-carrying plasmids and highlighting previously overlooked plasmids that necessitate close monitoring.
- Open Access
- 19 April 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (8) , 4494
Molecular Epidemiology of Carbapenem-Resistant Klebsiella aerogenes in Japan
Information regarding Klebsiella aerogenes haboring carbapenemase in Japan is limited. A comprehensive nationwide survey was conducted from September 2014 to December 2022, and 67 non-duplicate strains of carbapenem-resistant K. aerogenes were isolated from 57 healthcare facilities in Japan. Through genetic testing and whole-genome sequencing, six strains were found to possess carbapenemases, including imipenemase (IMP)-1, IMP-6, New Delhi metallo-β-lactamase (NDM)-1, and NDM-5. The strain harboring blaNDM-5 was the novel strain ST709, which belongs to the clonal complex of the predominant ST4 in China. The novel integron containing blaIMP-1 featured the oxacillinase-101 gene, which is a previously unreported structure, with an IncN4 plasmid type. However, integrons found in the strains possessing blaIMP-6, which were the most commonly identified, matched those reported domestically in Klebsiella pneumoniae, suggesting the prevalence of identical integrons. Transposons containing blaNDM are similar or identical to the transposon structure of K. aerogenes harboring blaNDM-5 previously reported in Japan, suggesting that the same type of transposon could have been transmitted to K. aerogenes in Japan. This investigation analyzed mobile genetic elements, such as integrons and transposons, to understand the spread of carbapenemases, highlighting the growing challenge of carbapenem-resistant Enterobacterales in Japan and underscoring the critical need for ongoing surveillance to control these pathogens.
- 19 April 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (8) , 4494
Open AccessMolecular Epidemiology of Carbapenem-Resistant Klebsiella aerogenes in Japan
Information regarding Klebsiella aerogenes haboring carbapenemase in Japan is limited. A comprehensive nationwide survey was conducted from September 2014 to December 2022, and 67 non-duplicate strains of carbapenem-resistant K. aerogenes were isolated from 57 healthcare facilities in Japan. Through genetic testing and whole-genome sequencing, six strains were found to possess carbapenemases, including imipenemase (IMP)-1, IMP-6, New Delhi metallo-β-lactamase (NDM)-1, and NDM-5. The strain harboring blaNDM-5 was the novel strain ST709, which belongs to the clonal complex of the predominant ST4 in China. The novel integron containing blaIMP-1 featured the oxacillinase-101 gene, which is a previously unreported structure, with an IncN4 plasmid type. However, integrons found in the strains possessing blaIMP-6, which were the most commonly identified, matched those reported domestically in Klebsiella pneumoniae, suggesting the prevalence of identical integrons. Transposons containing blaNDM are similar or identical to the transposon structure of K. aerogenes harboring blaNDM-5 previously reported in Japan, suggesting that the same type of transposon could have been transmitted to K. aerogenes in Japan. This investigation analyzed mobile genetic elements, such as integrons and transposons, to understand the spread of carbapenemases, highlighting the growing challenge of carbapenem-resistant Enterobacterales in Japan and underscoring the critical need for ongoing surveillance to control these pathogens.
- Open Access
Epidemiological Characteristics of Carbapenem-Resistant Enterobacterales in Japan: A Nationwide Analysis of Data from a Clinical Laboratory Center (2016–2022)
In Japan, nationwide epidemiological surveys on carbapenem-resistant Enterobacterales (CREs), including comprehensive information, are scarce, with most data available only through public reports. This study analyzed data on the Enterobacterales family collected from nationwide testing centers between January 2016 and December 2022, focusing on isolates that met the criteria for CRE in Japan based on drug susceptibility. We investigated 5,323,875 Enterobacterales isolates of 12 different species; among 4696 (0.09%) CRE strains, the proportion of major CRE isolates was as follows: Escherichia coli, 31.3%; Klebsiella pneumoniae, 28.0%; Enterobacter cloacae, 18.5%; and Klebsiella aerogenes, 6.7%. Moreover, over a 7-year period, Providencia rettgeri, E. cloacae, K. aerogenes, and K. pneumoniae demonstrated relatively high CRE percentages of 0.6% (156/26,185), 0.47% (869/184,221), 0.28% (313/110,371), and 0.17% (1314/780,958), respectively. The number of CRE strains isolated from different samples was as follows: urine, 2390; respiratory specimens, 1254; stool, 425; blood, 252; others, 375. In the broader context, including colonization, the predominant isolates of CREs collected at nationwide testing centers are E. coli and K. pneumoniae. Furthermore, recently, attention has been directed toward less common CRE species, such as Klebsiella oxytoca and Providencia rettgeri, and thus, it might be necessary to continue monitoring these less common species.
Open AccessEpidemiological Characteristics of Carbapenem-Resistant Enterobacterales in Japan: A Nationwide Analysis of Data from a Clinical Laboratory Center (2016–2022)
In Japan, nationwide epidemiological surveys on carbapenem-resistant Enterobacterales (CREs), including comprehensive information, are scarce, with most data available only through public reports. This study analyzed data on the Enterobacterales family collected from nationwide testing centers between January 2016 and December 2022, focusing on isolates that met the criteria for CRE in Japan based on drug susceptibility. We investigated 5,323,875 Enterobacterales isolates of 12 different species; among 4696 (0.09%) CRE strains, the proportion of major CRE isolates was as follows: Escherichia coli, 31.3%; Klebsiella pneumoniae, 28.0%; Enterobacter cloacae, 18.5%; and Klebsiella aerogenes, 6.7%. Moreover, over a 7-year period, Providencia rettgeri, E. cloacae, K. aerogenes, and K. pneumoniae demonstrated relatively high CRE percentages of 0.6% (156/26,185), 0.47% (869/184,221), 0.28% (313/110,371), and 0.17% (1314/780,958), respectively. The number of CRE strains isolated from different samples was as follows: urine, 2390; respiratory specimens, 1254; stool, 425; blood, 252; others, 375. In the broader context, including colonization, the predominant isolates of CREs collected at nationwide testing centers are E. coli and K. pneumoniae. Furthermore, recently, attention has been directed toward less common CRE species, such as Klebsiella oxytoca and Providencia rettgeri, and thus, it might be necessary to continue monitoring these less common species.